Although Aβ overload is believed to be the most important risk factor for AD development, it is worth noting that there are a great many people bearing Aβ plaques in their brains who do not exhibit dementia symptoms unless the tau pathology or cerebral amyloid angiopathy (CAA) occurs. Here, MAPT is linked to Alzheimer disease.